Central Bank & Trust’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-360
Closed -$119K – 215
2024
Q2
$119K Hold
360
– – 0.02% 198
2024
Q1
$131K Hold
360
– – 0.02% 193
2023
Q4
$108K Hold
360
– – 0.02% 201
2023
Q3
$103K Hold
360
– – 0.02% 192
2023
Q2
$101K Sell
360
-4
-1% -$1.04K 0.02% 192
2023
Q1
$93K Buy
364
+4
+1% +$1.17K 0.02% 197
2022
Q4
$119K Hold
360
– – 0.02% 191
2022
Q3
$100K Hold
360
– – 0.02% 188
2022
Q2
$95K Hold
360
– – 0.02% 197
2022
Q1
$86K Hold
360
– – 0.01% 206
2021
Q4
$83K Hold
360
– – 0.01% 207
2021
Q3
$72K Sell
360
-189
-34% -$41.1K 0.01% 205
2021
Q2
$130K Hold
549
– – 0.02% 186
2021
Q1
$133K Buy
549
+189
+53% +$42.1K 0.02% 172
2020
Q4
$75K Hold
360
– – 0.01% 187
2020
Q3
$61K Hold
360
– – 0.01% 186
2020
Q2
$68K Hold
360
– – 0.01% 172
2020
Q1
$64K Hold
360
– – 0.02% 168
2019
Q4
$74K Hold
360
– – 0.01% 170
2019
Q3
$55K Hold
360
– – 0.01% 180
2019
Q2
$57K Hold
360
– – 0.01% 174
2019
Q1
$58K Hold
360
– – 0.01% 179
2018
Q4
$68K Buy
+360
New +$75.1K 0.02% 157
2016
Q4
– Sell
-23
Closed -$3K – 323
2016
Q3
$3K Buy
+23
New +$3K ﹤0.01% 303

Other funds holding CI

Central Bank & Trust's CI Position: Q3 2024 in Review

Central Bank & Trust sold out of Cigna (CI) in Q3 2024, closing a stake of 360 shares — an estimated $119K sold.

Central Bank & Trust first reported a position in CI in Q3 2016 and held it in 24 quarters. The position peaked at $133K in Q1 2021. 1,706 funds tracked by Wall St. Rank hold CI as of Q3 2024.

  • Central Bank & Trust reported no remaining Cigna position as of Q3 2024 after selling out during the quarter.
  • Central Bank & Trust sold 360 Cigna shares in Q3 2024, an estimated $119K.
  • Central Bank & Trust first reported a position in Cigna in Q3 2016 and held it in 24 quarters.
  • Central Bank & Trust's Cigna position peaked at $133K in Q1 2021.
  • 1,706 funds tracked by Wall St. Rank held Cigna as of Q3 2024.

Based on Central Bank & Trust's 13F filing for Q3 2024, filed 30 Oct 2024.